In this special edition of Plant Rants, we take a look at the TGA’s 2025 consultation paper.

With the help of our AI journalists Charlene and Chadwick, this episode peels back the layers of bias and risk-centric framing.

So whose voices are being heard? Whose experiences actually count? And how do the lived realities of thousands of patients, who are seeing life-changing benefits from medicinal cannabis, stack up against the official risk-heavy framing of regulators?

This episode deep dives into:

• The consultation’s overwhelming focus on risks and hazards.
• Real-world patient outcomes, like massive opioid reduction, improved quality of life, and even return-to-work rates.
• Why ignoring dosing, supervision, and episodic use misses the fundamentals of pharmacology.
• Join The Patients movement fighting to ensure lived experience is central to the policy conversation.

📢 Call to action:
Read the document. Make your own decisions.

And most importantly, please get involved. The consultation period closes on 7 October 2025. Don’t miss the chance to have your say.
https://consultations.tga.gov.au/medicines-regulation-division/test-soms/

🔗 Join the movement at https://www.thepatients.au/